"LiverColor": Machine Learning in Liver Photographs

Sponsor
Hospital Vall d'Hebron (Other)
Overall Status
Recruiting
CT.gov ID
NCT05202886
Collaborator
(none)
246
1
1
66
3.7

Study Details

Study Description

Brief Summary

The main goal of this project is to create a machine learning model in order to quantify liver steatosis in liver donor faster, more objective and reliable than histological analysis and surgeons point-of-view.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Liver from deceased donors
N/A

Detailed Description

Surgeons (junior and senior operators) from the HBP & Transplantation Unit took the pictures. They were taken after the laparotomy and before any type of surgical procedure. For each deceased donor case, a total of 5 pictures were taken: one for the left lobe and another for the right one before undergoing a surgical biopsy, two more (one for the left and one for the right lobe) after the histological analysis, near to the site of the surgical biopsy, and finally, one picture after liver perfusion.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
246 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Liver from deceased donorsLiver from deceased donors
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
"LiverColor": AN ALGORITHM QUANTIFICATION OF LIVER GRAFT STEATOSIS USING MACHINE LEARNING AND COLOR IMAGE PROCESSING
Actual Study Start Date :
Jun 30, 2018
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Liver from deceased donors

This study included all consecutive subjects with chronic liver disease who underwent LT for the first time with a deceased donor liver

Diagnostic Test: Liver from deceased donors
Liver donors photographed

Outcome Measures

Primary Outcome Measures

  1. The main goal of this project is to create a machine learning model in order to quantify liver steatosis in liver donor faster, more objective and reliable than histological analysis and surgeons point-of-view. [4 weeks]

    Accuracy

Secondary Outcome Measures

  1. To build an image dataset to evaluate postransplant liver function. [1 week]

    PDF will be evaluated according to Olthoff criteria

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Livers from donor donor brain death with informed consent before inclusion in the study was obtained from all participants or families.
Exclusion Criteria:
  • Age < 18 years old

  • Donor after cardiac death

  • Split

  • Cholestasis due to a biliary obstruction

  • Total bilirubin levels above 2,5 mg/dL

  • Glutamic oxaloacetic transaminase (SGOT)/ serum glutamatepyruvate transaminase (SGPT) levels and gamma-glutamyl transaminase (GGT) levels above 400 U/L

  • Cirrhotic livers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Concepción Gómez-Gavara Barcelona Spain

Sponsors and Collaborators

  • Hospital Vall d'Hebron

Investigators

  • Principal Investigator: Concepcion Gómez-Gavara, PhD, Vall D´Hebron University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Concepción Gomez Gavara, PhD, Hospital Vall d'Hebron
ClinicalTrials.gov Identifier:
NCT05202886
Other Study ID Numbers:
  • PR(AG)04/2018
First Posted:
Jan 24, 2022
Last Update Posted:
Jan 24, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Concepción Gomez Gavara, PhD, Hospital Vall d'Hebron
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2022